Dimensional Fund Advisors LP Inmune Bio, Inc. Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 25,139 shares of INMB stock, worth $46,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,139
Previous 25,139
-0.0%
Holding current value
$46,758
Previous $196,000
70.41%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding INMB
# of Institutions
97Shares Held
6.3MCall Options Held
1.63MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.58 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.51 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.11 Million45.87% of portfolio
-
Ubs Group Ag449KShares$835,5510.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$725,2710.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $33.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...